Clinical trial

Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

NCT06386107

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-09-02

PhaseNA

Study timeline

Study start (actual)2025-09-02Date precision: day

Registry last updated2026-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Pulmonary Embolismunresolved

Thrombosisunresolved

Interventions

Thrombin Generation Assay (TGA)BIOLOGICAL

Sponsors & collaborators

Centre Hospitalier Universitaire de Saint Etiennelead sponsor

Diagnostica Stagocollaborator

LEO Pharmacollaborator

Ligue contre le cancer, Francecollaborator

Mapped research locations

LyonFrance1 Clermont-FerrandFrance1 GrenobleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06386107 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.